Gynecology Collaboration and Licensing Deals 2016-2026

Description

The definitive benchmark for gynecology dealmaking

Gynecology partnering spans a range of indications within women's health, with deal structures reflecting a combination of innovation, lifecycle management, and specialized commercial strategies.

This report provides a comprehensive and structured analysis of 157 gynecology collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how gynecology deals are structured in practice, allowing you to:

Benchmark comparable transactions with confidence
Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
Define realistic market parameters
Clear insight into how deal terms vary by stage, asset type, and partner profile
Support valuation and structuring decisions with evidence
Ground internal discussions in real transaction data rather than assumptions
Understand how leading companies approach dealmaking
Visibility into partner behaviour and recurring deal structures across a specialized and evolving women's health landscape
Full visibility into deal structure and execution
Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

Rights granted and retained
Development and commercialization responsibilities
Financial structures and payment triggers
Key contractual provisions and protections
This level of transparency is critical to understanding how value, risk, and control are allocated within gynecology partnerships, particularly in areas shaped by distinct clinical pathways and commercial considerations.
Designed for real-world BD and strategy use

The report is widely used to:

Structure and benchmark live transactions
Prepare for negotiations with well-defined market context
Evaluate partnership opportunities and counterparties
Support internal strategy with robust, defensible data
What's included
157 gynecology collaboration and licensing deals
Financial terms, including upfronts, milestones, and royalties where disclosed
Fully searchable deal directory (by company, therapy, and technology)
Direct access to SEC-filed agreements and source documents
Analysis of deal trends, key transactions, and active dealmakers
A trusted, evidence-based reference for gynecology dealmaking
Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how gynecology partnerships are structured, negotiated, and valued.

Product Code: CP2211

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in gynecology dealmaking

2.1. Introduction
2.2. Gynecology partnering over the years
2.3. Gynecology partnering by deal type
2.4. Gynecology partnering by industry sector
2.5. Gynecology partnering by stage of development
2.6. Gynecology partnering by technology type
2.7. Gynecology partnering by therapeutic indication

Chapter 3 - Financial deal terms for gynecology partnering

3.1. Introduction
3.2. Disclosed financials terms for gynecology partnering
3.3. Gynecology partnering headline values
3.4. Gynecology deal upfront payments
3.5. Gynecology deal milestone payments
3.6. Gynecology royalty rates

Chapter 4 - Leading gynecology deals and dealmakers

4.1. Introduction
4.2. Most active in gynecology partnering
4.3. List of most active dealmakers in gynecology
4.4. Top gynecology deals by value

Chapter 5 - Gynecology contract document directory

5.1. Introduction
5.2. Gynecology partnering deals where contract document available

Chapter 6 - Gynecology dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by gynecology therapeutic target
Deal directory
Deal directory - Gynecology deals by company A-Z
Deal directory - Gynecology deals by technology type
Deal type definitions
About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Gynecology partnering since 2016
Figure 2: Gynecology partnering by deal type since 2016
Figure 3: Gynecology partnering by industry sector since 2016
Figure 4: Gynecology partnering by stage of development since 2016
Figure 5: Gynecology partnering by technology type since 2016
Figure 6: Gynecology partnering by indication since 2016
Figure 7: Gynecology deals with a headline value
Figure 8: Gynecology deals with upfront payment values
Figure 9: Gynecology deals with milestone payment
Figure 10: Gynecology deals with royalty rates
Figure 11: Active gynecology dealmaking activity since 2016
Figure 12: Top gynecology deals by value since 2016